Saccharomyces boulardii for the Prevention of Hospital Onset Clostridium difficile Infection
Open Access
- 1 March 2015
- journal article
- research article
- Published by Romanian Society of Gastroenterology and Hepatology in Journal Of Gastrointestinal and Liver Diseases
- Vol. 24 (1), 21-24
- https://doi.org/10.15403/jgld.2014.1121.fly
Abstract
Background & Aims: Probiotics, including Saccharomyces boulardii, have been advocated for the prevention of Clostridium difficile infection. The aim of this project was to evaluate the effects of the removal of S. boulardii from an automatic antibiotic order set and hospital formulary on hospital onset C. difficile infection rates. Method. Design: A retrospective chart review was performed on all patients with hospital onset C. difficile infection during the 13 months prior (control group) and the 13 months after (study group) removal of an automatic order set linking S. boulardii capsules to certain broad spectrum antibiotics. Setting: A large 800+ bed tertiary hospital Results: Among all hospitalized patients, the rate of hospital onset C. difficile infection was 0.99 per 1000 patient days while the S. boulardii protocol was active compared with 1.04 per 1000 patient days (p=0.10) after S. boulardii was removed from the formulary. No difference in the rate of hospital onset C. difficile infection was detected in patients receiving the linked broad spectrum antibiotics during and after the removal of the protocol (1.25% vs. 1.51%, respectively; p=0.70). Conclusions: Removal of S. boulardii administration to patients receiving broad spectrum antibiotics and the hospital formulary did not impact the rate of hospital onset C. difficile infection in either the hospital population or patients receiving broad spectrum antibiotics.Keywords
This publication has 7 references indexed in Scilit:
- Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 UpdateInfection Control & Hospital Epidemiology, 2014
- Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysisJournal of Antimicrobial Chemotherapy, 2013
- Probiotics for the Prevention ofClostridium difficile–Associated DiarrheaAnnals of Internal Medicine, 2012
- Preventing downstream Clostridium difficile infections with upstream antibiotic managementMedical Hypotheses, 2012
- Evaluation of the C.Diff Quik Chek Complete Assay, a New Glutamate Dehydrogenase and A/B Toxin Combination Lateral Flow Assay for Use in Rapid, Simple Diagnosis of Clostridium difficile DiseaseJournal of Clinical Microbiology, 2010
- Decreased Diversity of the Fecal Microbiome in RecurrentClostridium difficile–Associated DiarrheaThe Journal of Infectious Diseases, 2008
- Meta-Analysis of Probiotics for the Prevention of Antibiotic Associated Diarrhea and the Treatment of Clostridium difficile DiseaseThe American Journal of Gastroenterology, 2006